These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10194656)

  • 21. Fosinopril: a new generation of angiotensin-converting enzyme inhibitors.
    Weber MA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 10():S7-12. PubMed ID: 1283429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post acute myocardial infarction: the Fosinopril in Acute Myocardial Infarction Study (FAMIS).
    Borghi C; Marino P; Zardini P; Magnani B; Collatina S; Ambrosioni E
    Am J Hypertens; 1997 Oct; 10(10 Pt 2):247S-254S. PubMed ID: 9366281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic ACE-inhibitor treatment and adrenergic mechanisms in spontaneously hypertensive rats.
    Castellano M; Rizzoni D; Beschi M; Böhm M; Porteri E; Bettoni G; Cinelli A; Rosei EA
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):381-7. PubMed ID: 8583778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition.
    Intengan HD; Thibault G; Li JS; Schiffrin EL
    Circulation; 1999 Nov; 100(22):2267-75. PubMed ID: 10578002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
    Litwin SE; Katz SE; Weinberg EO; Lorell BH; Aurigemma GP; Douglas PS
    Circulation; 1995 May; 91(10):2642-54. PubMed ID: 7743628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
    Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
    Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
    MacFadyen RJ; Lee AF; Morton JJ; Pringle SD; Struthers AD
    Heart; 1999 Jul; 82(1):57-61. PubMed ID: 10377310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal baroreceptor-mediated vasodilation of the peripheral circulation in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Wroblewski H; Kastrup J; Mortensen SA; Haunsø S
    Circulation; 1993 Mar; 87(3):849-56. PubMed ID: 8443905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy.
    Sørensen VB; Rossing P; Tarnow L; Parving H; Nørgaard T; Kastrup J
    Clin Sci (Lond); 1998 Dec; 95(6):709-17. PubMed ID: 9831696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amlodipine monotherapy, angiotensin-converting enzyme inhibition, and combination therapy with pacing-induced heart failure.
    Kribbs SB; Merritt WM; Clair MJ; Krombach RS; Houck WV; Dodd MG; Mukherjee R; Spinale FG
    Hypertension; 1998 Mar; 31(3):755-65. PubMed ID: 9495258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Fosinopril Heart Failure Study Group.
    Brown EJ; Chew PH; MacLean A; Gelperin K; Ilgenfritz JP; Blumenthal M
    Am J Cardiol; 1995 Mar; 75(8):596-600. PubMed ID: 7887385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The angiotensin converting enzyme inhibitors fosinopril and enalapril differ in their central nervous effects in humans.
    Derad I; Otterbein A; Mölle M; Pietrowsky R; Born J; Fehm HL
    J Hypertens; 1996 Nov; 14(11):1309-15. PubMed ID: 8934359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged effects of short-term fosinopril on blood pressure and vascular morphology and function in rats.
    Rizzoni D; Castellano M; Porteri E; Bettoni G; Muiesan ML; Cinelli A; Zulli R; Rosei EA
    Am J Hypertens; 1997 Sep; 10(9 Pt 1):1034-43. PubMed ID: 9324110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term angiotensin-converting enzyme inhibition with fosinopril improves depressed responsiveness to Ca2+ in myocytes from aortic-banded rats.
    Kagaya Y; Hajjar RJ; Gwathmey JK; Barry WH; Lorell BH
    Circulation; 1996 Dec; 94(11):2915-22. PubMed ID: 8941121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.
    Hayek T; Attias J; Coleman R; Brodsky S; Smith J; Breslow JL; Keidar S
    Cardiovasc Res; 1999 Dec; 44(3):579-87. PubMed ID: 10690290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fosinopril. Clinical pharmacokinetics and clinical potential.
    Shionoiri H; Naruse M; Minamisawa K; Ueda S; Himeno H; Hiroto S; Takasaki I
    Clin Pharmacokinet; 1997 Jun; 32(6):460-80. PubMed ID: 9195116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men.
    Reneland R; Haenni A; Andersson PE; Andrén B; Lithell H
    Blood Press; 1999; 8(1):16-22. PubMed ID: 10412878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of angiotensin-converting enzyme inhibition by fosinopril on myocardial perfusion in streptozotocin-diabetic rats.
    Rösen P; Rump AF; Rösen R
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):64-70. PubMed ID: 8656660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.